A 12-week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of Lactiplantibacillus plantarum NCHBL-004 on reducing body fat
Not Applicable
Recruiting
- Conditions
- Endocrine, nutritional and metabolic diseases
- Registration Number
- KCT0009308
- Lead Sponsor
- odCure
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
BMI 25 ~ 30 kg/m2
Exclusion Criteria
A person currently under treatment for severe cardiovascular, immune, respiratory, gastrointestinal/hepatic and biliary systems, kidney and urinary systems, nervous systems, psychotropic, infectious diseases and malignant tumors.
A person who has had obesity surgery within a year.
A person who has taken a drug that affects his or her weight within one month.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body fat mass
- Secondary Outcome Measures
Name Time Method Rate of body fat mass, Total fat mass;Body weight, Body Mass Index(BMI);Waist and hip circumference, waist/hip circumference ratio;Total abdominal fat area, visceral fat area, subcutaneous fat area, visceral/subcutaneous fat area ratio;Blood Lipid;Assessment of improvement in bowel symptoms (ROME IV);Survey of Intestinal Health Symptoms